The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of quality of life in patients randomized to high-dose once daily (QD) thoracic radiotherapy (TRT) with standard twice daily (BID) TRT in limited stage small cell lung cancer (LS-SCLC) on CALGB 30610 (Alliance, Sub-study CALGB 70702).
 
Apar Kishor Ganti
Consulting or Advisory Role - AstraZeneca; Beigene; Blueprint Medicines; Cardinal Health; Cardinal Health; Flagship Biosciences; G1 Therapeutics; Genentech/Roche; Genzyme; Jazz Pharmaceuticals; Mirati Therapeutics
Research Funding - Apexigen (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Novartis (Inst); Takeda; TopAlliance BioSciences Inc (Inst)
 
Amylou C. Dueck
Patents, Royalties, Other Intellectual Property - Royalties from licensing fees for a patient symptom questionnaire (MPN-SAF)
 
Briant Fruth
No Relationships to Disclose
 
Andreas Rimner
Honoraria - More Health
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Pfizer (Inst); Varian Medical Systems (Inst)
 
Saiama Naheed Waqar
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Checkpoint Therapeutics (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Hengrui Therapeutics (Inst); Ignyta (Inst); Lilly (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Spectrum Pharmaceuticals (Inst); Stem CentRx (Inst); Synermore biologics (Inst); Vertex (Inst); Xcovery (Inst)
 
Michael D Mix
No Relationships to Disclose
 
William J. Petty
Consulting or Advisory Role - Jazz Pharmaceuticals; Mirati Therapeutics
Research Funding - Abbvie (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Dava Oncology
 
Jeffrey A Bogart
Stock and Other Ownership Interests - Cardan Robotics; Verve Medical